Skip to main content
. 2016 Jul 11;2016(7):CD011195. doi: 10.1002/14651858.CD011195.pub2
Outcomes relevant to your review
Copy and paste from ‘Types of outcome measures’
  Reported in paper (circle)
Overall mortality Yes/No
Overall 28‐day mortality (30 days M included) Yes/No
Time required for clearance of blood culture for Candida species Yes/No
Frequency of persistent candidaemia
(positive culture after 3 days of effective antifungal therapy)
Yes/No
Complications probably related to candidaemia (e.g. metastatic foci, endocarditis, endophthalmitis, hepatosplenic candidosis) Yes/No
Complications probably related to the intervention (e.g. pneumothorax, arterial puncture, bleeding requiring blood transfusion, local suppurative complications) Yes/No
Complications during in‐patient stay not specific to trial intervention (e.g. pneumonia, congestive heart failure, respiratory failure, renal failure) Yes/No
Duration of mechanical ventilation Yes/No
Ventilator‐free days Yes/No
Mean length of stay in hospital Yes/No
Mean length of stay in intensive care unit (ICU) Yes/No
Species‐related mortality Yes/No